Clinical Scorecard: Enhanced Immune Response to Influenza Vaccination Observed in Patients with Decompensated Liver Cirrhosis Associated with Systemic Inflammation
At a Glance
Category
Detail
Condition
Key Mechanisms
Target Population
Patients with compensated and decompensated liver cirrhosis, with a clear definition of each stage.
Care Setting
Key Highlights
Patients with liver cirrhosis exhibit stronger vaccine-induced immune responses compared to healthy individuals, with notable differences between compensated and decompensated stages.
Enhanced immune responses are particularly pronounced in patients with decompensated liver cirrhosis.
Distinct serum cytokine and metabolite profiles are linked to vaccine response in cirrhosis patients, varying by cirrhosis stage.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Evaluate humoral and cellular immune responses post-vaccination through serology and cytokine profiling, including specific metrics such as antibody titers and cytokine levels.
Risks
Patient & Prescribing Data
Vaccination coverage in liver cirrhosis patients remains low despite recommendations, with recent studies indicating rates below 30%.
Clinical Best Practices
Implement stringent vaccination regimes for patients with liver cirrhosis, including reminders for annual vaccination.
Consider baseline immune signatures, such as cytokine levels, to predict vaccination outcomes and tailor vaccination strategies.
by Janyn Heisig, Valerie Ohlendorf, Nhan Nguyen, Peggy Riese, Stephanie Trittel, Liang Zhou, Ahmed Alaswad, Heiner Wedemeyer, Anke Kraft, Yang Li, Markus Cornberg, Carlos A. Guzmán, Benjamin Maasoumy
The CDC has dropped routine recommendations for six childhood vaccines, shifting decisions to parents and doctors despite decades of evidence showing the shots prevented millions of hospitalizations and tens of thousands of deaths.
